Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jun Hyung Lee
Observed names:
Junhyung Isaac Lee,
Lee, Jun Hyung
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
Observed institutions:
Korea University,
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
Korea University,
The Ohio State University
ORCID:
0000-0002-0954-7569
Observed ORCID:
0000-0002-0954-7569
OpenAlex ID:
A5049576455
Sound Demixing Challenge 2023 Music Demixing Track Technical Report: TFC-TDF-UNet v3
2023
·
Kim, Minseok
, Lee, Jun Hyung
, et al.
·
arXiv (Cornell University)
·
23
PDF
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy
2023
·
Joseph Kim
, Dong-In Koh
, et al.
·
Cell Death and Differentiation
·
7
PDF
The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
·
Cancer Immunology Research
·
4
PDF
A dual assault on KRAS
2026
·
Dasom Kim
, Junhyung Isaac Lee
, et al.
·
Nature Chemical Biology
Supplementary Figure 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 8 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 3 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Table 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 4 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 9 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 7 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Table 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 5 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 6 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2026
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 7 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Table 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Table 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 6 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 3 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Table 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 5 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 8 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Supplementary Figure 9 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024
·
Dong-In Koh
, Minki Lee
, et al.
Show more works
View as search
Works count:
30
Citation count:
34
H-index:
3
I10-index:
1
Year
Topic
Type